APA (7th ed.) Citation

CN, Y., YS, S., CY, Y., CF, H., CH, T., CC, W., . . . HJ, T. (2026). A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study. Experimental and therapeutic medicine, 31(5), 145. https://doi.org/10.3892/etm.2026.13140

Chicago Style (17th ed.) Citation

CN, Yeh, et al. "A Nomogram for Predicting Recurrence-free Survival in Patients with High-risk GIST Receiving Adjuvant Imatinib: A Nationwide Registry Study." Experimental and Therapeutic Medicine 31, no. 5 (2026): 145. https://doi.org/10.3892/etm.2026.13140.

MLA (9th ed.) Citation

CN, Yeh, et al. "A Nomogram for Predicting Recurrence-free Survival in Patients with High-risk GIST Receiving Adjuvant Imatinib: A Nationwide Registry Study." Experimental and Therapeutic Medicine, vol. 31, no. 5, 2026, p. 145, https://doi.org/10.3892/etm.2026.13140.